Newsletter | September 15, 2023

09.15.23 -- 4 Ways For An Edge In the Talent Shortage


Is the growing demand for small molecule outsourcing impeding your ability to find a reliable partner with capacity? Don’t miss Outsourced Pharma Capacity Update — a virtual event focused entirely on the available capacity and related service area capabilities, volumes, locations, and facilities of CDMOs. This multiday event is conveniently grouped by molecule type and will feature small molecule partner presentations on October 4th. Registration is free.


4 Ways To Gain A Competitive Edge In This Biopharma Talent Shortage

It’s no secret that finding pharma/biotech manufacturing talent is challenging, and the lack of workers is having a negative impact on productivity and growth. Here are four effective strategies for recruiting, training, educating, and retaining your workforce.

Geopartnering With Global Suppliers

Andrew Trigwell of Paradigm BioPharmaceuticals in Australia, deals in distances. He can teach you how long-distance outsourcing can work, and how to meet the challenges of a global supply chain.

WuXi Biologics 2023 CDMO Leadership Awards Winner Interview

Weichang Zhou, president of global biologics development and operations and CTO, sits down with Outsourced Pharma chief editor Louis Garguilo at the CDMO Leadership Awards to discuss WuXi Biologics' win in the Capabilities category, the role of technology in outsourcing, and how today's partners are focused on innovation. Congratulations again, Weichang and WuXi!


Harness High-Quality PBPK Modeling To Enhance Clinical Readiness

PBPK modeling advancements are helping to identify poor absorption properties early in development, enabling sponsors to mitigate risk in preclinical and clinical studies.

Nanoparticle Engineering: Revolutionizing Oral Drug Delivery

Nanoparticle engineering has emerged as a promising solution to enhance drug solubility and bioavailability and thus improve efficiency within the drug development pipeline.

Prioritize Safety And Mitigate Risk In HPAPI Manufacturing

As highly potent APIs become increasingly common across the industry, it is critical to work with partners who use a risk-based approach to ensure safety and quality.

Seamlessly Transitioning From Clinical Phases To Commercial Readiness

A CDMO with deep team expertise in developing and manufacturing injectable products “from bench to batch” can help ensure that you complete your project on time.

Designing An Optimal APAC Clinical Supply Chain

Learn how to navigate the complex clinical supply distribution landscape within this important and growing region.

Tech Transfer In Sterile Injectables: 3 Phases Of Success

Explore the three phases of sterile injectable project tech transfer, including how to bridge information gaps and facilitate successful regulatory filing during this stage.


Patient-Centric Solutions: Taste Masking

Taste, smell, and mouthfeel are key features for pediatric formulations. Cost-effective solutions with flexibility in manufacturing are essential to overcome challenges.

High Potent APIs

Discover how Cambrex can reliably develop and manufacture a broad spectrum of HPAPIs and compounds.


Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.


More On The Modalities That Matter To You

The Outsourced Pharma newsletter delivers daily outsourcing insights for specific therapeutic modalities. On Mondays and Thursdays, we cover Biologics outsourcing. On Tuesdays, Cell & Gene Therapies. And on Wednesdays and Fridays, Small Molecule DrugsUpdate your topic preferences to receive the newsletter(s) of interest to you.

Connect With Outsourced Pharma: